YB1 modulates the DNA damage response in medulloblastoma

• Published in: Scientific reports 2023-05, Vol.13 (1), p.8087-8087, Article 8087
• Main Authors: McSwain, Leon F., Pillsbury, Claire E., Haji-Seyed-Javadi, Ramona, Rath, Sandip Kumar, Chen, Victor, Huang, Tiffany, Shahab, Shubin W., Kunhiraman, Haritha, Ross, James, Price, Gabrielle A., Dey, Abhinav, Hambardzumyan, Dolores, MacDonald, Tobey, Yu, David S., Porter, Christopher C., Kenney, Anna M.
• Format: Article
• Language: English
• Subjects: 631/67; 631/67/2332; 631/80; 692/4028; Animals; Brain cancer; Brain Neoplasms - metabolism; Brain tumors; Cell cycle; Cell Proliferation; Cerebellar Neoplasms - pathology; Cerebellum; Chemotherapy; Cisplatin; Deoxyribonucleic acid; DNA; DNA Damage; DNA repair; Hedgehog protein; Hedgehog Proteins - metabolism; Homologous recombination; Humanities and Social Sciences; Humans; Ionizing radiation; Medulloblastoma; Medulloblastoma - pathology; Mice; multidisciplinary; Neural Stem Cells - metabolism; Non-homologous end joining; Pediatrics; Platinum; Protein interaction; Proteins; Radiation; Radiation standards; Radiation therapy; Science; Science (multidisciplinary); Senescence; Y-Box-Binding Protein 1 - metabolism
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-023-35220-6

Y-box binding protein 1 ( YBX1 or YB1) is a therapeutically relevant oncoprotein capable of RNA and DNA binding and mediating protein–protein interactions that drive proliferation, stemness, and resistance to platinum-based therapies. Given our previously published findings, the potential for YB1-driven cisplatin resistance in medulloblastoma (MB), and the limited studies exploring YB1-DNA repair protein interactions, we chose to investigate the role of YB1 in mediating radiation resistance in MB. MB, the most common pediatric malignant brain tumor, is treated with surgical resection, cranio-spinal radiation, and platinum-based chemotherapy, and could potentially benefit from YB1 inhibition. The role of YB1 in the response of MB to ionizing radiation (IR) has not yet been studied but remains relevant for determining potential anti-tumor synergy of YB1 inhibition with standard radiation therapy. We have previously shown that YB1 drives proliferation of cerebellar granular neural precursor cells (CGNPs) and murine Sonic Hedgehog (SHH) group MB cells. While others have demonstrated a link between YB1 and homologous recombination protein binding, functional and therapeutic implications remain unclear, particularly following IR-induced damage. Here we show that depleting YB1 in both SHH and Group 3 MB results not only in reduced proliferation but also synergizes with radiation due to differential response dynamics. YB1 silencing through shRNA followed by IR drives a predominantly NHEJ-dependent repair mechanism, leading to faster γH2AX resolution, premature cell cycle re-entry, checkpoint bypass, reduced proliferation, and increased senescence. These findings show that depleting YB1 in combination with radiation sensitizes SHH and Group 3 MB cells to radiation.